ICON announces results from a global survey of biopharma professionals on AI and digital innovation adoption within clinical ...

First lady Jill Biden is looking to a post-White House future building on work she began while in office to shine a light on ...

ICON Public Limited (NASDAQ:ICLR – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are presently covering the firm, Ratings reports.

NEW YORK, Dec. 5, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The clinical trials market in US size is ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” ...

The new funding comes three months after Particle Health filed an antitrust lawsuit against electronic medical records giant ...

Larry Ellison's $165 million Oxford investment aims to transform research into products, in areas including health and clean ...

Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...

Canadian Institutes of Health Research, University of Calgary, Canada Correspondence to: Dr L McLaren Centre for Health and Policy Studies, G230, Health Sciences Centre, University of Calgary, 3330 ...

ICON Public Limited Company experiences short-term challenges but has solid long-term prospects. See why ICLR stock is a ...

Data from over 8,000 ALS patients will be fed into Unlearn's Digital Twin Generator, an AI platform that creates duplicates ...